Suchergebnisse - "Fähndrich, S"

PubPharm (20)

1

Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONET

enthalten in: Respiratory research | 2024

von Fähndrich, S. | Herr, C. | Teuteberg, S. | +54

2

Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD—results from COSYCONET

enthalten in: Respiratory research | 2024

von Fähndrich, S. | Herr, C. | Teuteberg, S. | +23

3

Alpha-1 Antitrypsin Deficiency (AATD) - D-A-CH-Expert Statement

enthalten in: Pneumologie (Stuttgart, Germany) | 2020

von Greulich, T. | Fähndrich, S. | Clarenbach, C. | +9

4

Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD : Results from COSYCONET

enthalten in: Scientific reports | 2020

von Trudzinski, F. | Jörres, R. | Alter, P. | +47

5

Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD : results from COSYCONET

enthalten in: Scientific reports | 29 June 2020

von Trudzinski, F. | Jörres, R. | Alter, P. | +15

6

Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD : Results from the COSYCONET cohort

enthalten in: Respiratory medicine | 2019

von Trudzinski, F. | Kahnert, K. | Vogelmeier, C. | +50

7

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort

in: International Journal of COPD | 2018

von Greulich T | Mager S | Lucke T | +8

8

Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency – analysis from the German Registry

in: International Journal of COPD | 2017

von Bernhard N | Lepper PM | Vogelmeier C | +4

9

Zystisch-destruierendes Wachstumsmuster eines Adenocarcinoms vom lepidischen Typ

enthalten in: Pneumologie | 2017

von Schmit, D. | Becker, S. | Trudzinski, F. | +7

10

Patienten mit Leberfunktionsstörungen an ECMO haben eine erhöhte Mortalität

enthalten in: Pneumologie | 2017

von Frank, A. | Feth, M. | Haab, M. | +7